Little Green Pharma’s subsidiary Reset Mind Sciences launches clinical trial using psilocybinCheyanne EncisoThe West AustralianThu, 11 January 2024 10:20AMCommentsCommentsPremiumEmail Cheyanne EncisoPremiumSubscribers with digital access can view this article.Already a subscriber?Login here.